INNOFFARENA-Innovasjonsarena for stat og kommune

PASG 2024 OSLO: Promoting the child´s best interests

PASG Norway is a non-profit voluntary organization aiming to building and disseminating knowledge about parental alienation and how children can be negatively influenced to distance themselves from a parent for no real reason, especially in connection with conflict between parents after a break-u...

Awarded: NOK 0.15 mill.

Project Period: 2024-2024

Location: Vestland

HELSEFORSKNING-Helseforskning

Improving personalised glioblastoma care by intertwined immunomics and artificial intelligence approaches

There is an urgent need for new treatment strategies to enhance both the care and quality of life for patients with glioblastoma (GBM). Despite advances in medical research, the standard treatment for GBM has remained unchanged for over 15 years, and the median survival time is still less than 15...

Awarded: NOK 4.0 mill.

Project Period: 2023-2027

Location: Oslo

BIOTEKNOLOGI-BIOTEKNOLOGI

KSP: CellFit - T cells fit to fight cancer

The concept of using the immune system to fight cancer, known as immunotherapy, is based on activating T-cells to attack cancer cells. To develop T-cell therapy, T-cells are isolated from the patient’s blood and equipped with specific receptors – proteins that enable the T-cells to recognize and ...

Awarded: NOK 22.5 mill.

Project Period: 2021-2025

Location: Oslo

BIOTEK2021-Bioteknologi for verdiskaping

Personalized Immunotherapy: Re-targeting T-cells against cancer

Adoptive T-cell therapy (ACT) is a type of immunotherapy where tumour-reactive T cells are expanded in the laboratory and then infused back into the patient. To increase the reactivity against the tumour, patient T cells can be modified to express a receptor which can bind to tumour cells and the...

Awarded: NOK 9.2 mill.

Project Period: 2015-2018

Location: Oslo